Preparing for 2021: Food and Drug Administration and Related Regulatory Challenges

During this program, our speakers discuss the Food and Drug Administration, as well as related regulatory challenges your business might face as we prepare for 2021. Topics include, but are not limited to: FDA enforcement and investigations; continuing focus on the supply chain, shortages and essential medicines; user fee reauthorization—developing issues; and FDA inspection challenges amid the continuing pandemic.